|
TMC310911
|
ASC-09
|
1000287-05-7
|
|
icapamespib
|
ICAPAMESPIB
|
1000999-96-1
|
|
BMS-820132
|
化合物 BMS-820132
|
1001419-18-6
|
|
SNX-0723
|
OGX-427
|
1002331-21-6
|
|
MMI-0100
|
細(xì)胞滲透性肽抑制劑多肽MMI-0100
|
1039342-24-9
|
|
Famitinib
|
法米替尼
|
1044040-56-3
|
|
Mometasone
|
莫美他松
|
105102-22-5
|
|
Cabotegravir sodium
|
卡博特韋鈉鹽
|
1051375-13-3
|
|
Cromakalim
|
色滿卡林
|
94470-67-4
|
|
C3a receptor agonist 1
|
2-環(huán)己基-2-苯基-N-[1-(3-吡啶-3-基丙?；?哌啶-4-基]乙酰胺
|
944997-60-8
|
|
Gypenoside L
|
絞股藍(lán)皂苷L
|
94987-09-4
|
|
Ipragliflozin (L-Proline)
|
伊格列凈L-脯氨酸
|
951382-34-6
|
|
Icerguastat
|
化合物SEPHIN 1
|
951441-04-6
|
|
Garcinone C
|
4-氨基-1-叔丁基-3-(3-甲基芐基)吡唑并[3,4-D]嘧啶
|
956025-83-5
|
|
Isolinderalactone
|
異烏藥內(nèi)酯
|
957-66-4
|
|
NCT-58
|
4-[[4-氨基-6-(5-氯-1H,3H-萘并[1,8-CD]吡喃-6-基)-1,3,5-三嗪-2-基]硫基]丁酰胺
|
959763-06-5
|
|
(E)-Akt inhibitor-IV
|
CS-1992
|
959841-49-7
|
|
(±)-Stylopine hydrochloride
|
鹽酸人血草堿
|
96087-21-7
|
|
DPI 201-106
|
SDZ-201 106 (+/-)
|
97730-95-5
|
|
Drotaverine hydrochloride
|
鹽酸屈他維林
|
985-12-6
|
|
Yadanzioside I
|
鴉膽子苷I
|
99132-95-3
|
|
ONO-RS-082
|
99754-06-0
|
99754-06-0
|
|
PRL-3 Inhibitor I
|
PRL-3 INHIBITOR I
|
893449-38-2
|
|
4SC-203
|
4SC-203
|
895533-09-2
|
|
DTHIB
|
Urea, N-(4-chloro-3-nitrophenyl)-N'-(4-fluorophenyl)-
|
897326-30-6
|
|
LpxH-IN-AZ1
|
LpxH-IN-AZ1
|
901260-40-0
|
|
E7016
|
化合物E7016
|
902128-92-1
|
|
Fucoidan
|
巖藻多糖
|
9072-19-9
|
|
Chymostatin
|
胰凝乳蛋白酶抑制劑
|
9076-44-2
|
|
AS1810722
|
化合物AS1810722
|
909561-15-5
|
|
Dasatinib N-oxide
|
達(dá)沙替尼N氧化物
|
910297-52-8
|
|
Gemigliptin
|
吉格列汀酒石酸鹽
|
911637-19-9
|
|
CMPDA
|
912574-69-7
|
912574-69-7
|
|
ABBV-318
|
1-CYCLOPENTYL-1,2-DIHYDRO-6',10',12'-TRIOXASPIRO[INDOLE-3,4'-TRICYCLO[7.3.0.0^{3,7}]DODECANE]-1',3'(7'),8'-TRIEN-2-ONE
|
912656-34-9
|
|
Ziconotide acetate
|
醋酸齊考諾肽
|
914454-03-8
|
|
Indimitecan
|
茚替康
|
915360-05-3
|
|
Felcisetrag
|
916075-84-8
|
916075-84-8
|
|
JH-XVI-178
|
7BIO
|
916440-85-2
|
|
TC-I 15
|
TC-I 15
|
916734-43-5
|
|
ML-SI3
|
ML-SI3
|
891016-02-7
|
|
EAAT2 activator 1
|
化合物T9347
|
892415-28-0
|
|
STD1T
|
STD1T
|
893075-58-6
|
|
SCH529074
|
SCH 529074
|
922150-11-6
|
|
P53R3
|
P53R3
|
922150-12-7
|
|
2-Phenyl-2-(1-piperidinyl)propane
|
1-(1-甲基-1-苯基乙基)哌啶
|
92321-29-4
|
|
HBX 41108
|
7-氯-9-氧代-9H-茚并[1,2-B]吡嗪-2,3-二甲腈
|
924296-39-9
|
|
BT44
|
BT-44
|
924759-42-2
|
|
AMTB hydrochloride
|
AMTB鹽酸鹽
|
926023-82-7
|
|
PQ-10
|
6,7-二甲氧基-4-[(3R)-3-(2-喹喔啉基氧基)-1-吡咯烷基]喹唑啉
|
927691-21-2
|
|
Naphthol AS-E
|
色酚 AS-E
|
92-78-4
|
|
AS1892802
|
AS 1892802
|
928320-12-1
|
|
HPN-01
|
HPN-01
|
928655-63-4
|
|
4-MMPB
|
15-Lipoxygenase Inhibitor 1
|
928853-86-5
|
|
IA-Alkyne
|
N-己-5-炔基-2-碘乙酰胺
|
930800-38-7
|
|
Dusquetide
|
Serlopitant
|
931395-42-5
|
|
DMT-dG(ib) Phosphoramidite
|
DMT-dG(ib)亞磷酰胺單體
|
93183-15-4
|
|
2-(Aminomethyl)phenol
|
2-羥基芐胺
|
932-30-9
|
|
Chamaechromone
|
狼毒色原酮
|
93413-00-4
|
|
QM31
|
QM31
|
937735-00-7
|
|
Difamilast
|
地法米司特
|
937782-05-3
|
|
(±)-N-3-Benzylnirvanol
|
(+/-)-N-3-Benzylnirvanol
|
93879-40-4
|
|
p53 and MDM2 proteins-interaction-inhibitor (chiral)
|
2-[4-[[(4S,5R)-4,5-雙(4-氯苯基)-2-[4-(1,1-二甲基乙基)-2-乙氧苯基]-4,5-二氫-4,5-二甲基-1H-咪唑-1-基]羰基]-1-哌嗪基]-1-(4-嗎啡啉)乙酮
|
939981-37-0
|
|
JK-P3
|
3,4-二甲氧基-N-(5-苯基-1H-吡唑-3-基)苯甲酰胺
|
942655-44-9
|
|
Miravirsen
|
MIRAVIRSEN
|
1072874-90-8
|
|
Retagliptin
|
Retagliptin
|
1174122-54-3
|
|
Otaplimastat
|
Remogliflozin etabonate
|
1176758-04-5
|
|
CP-609754
|
CP-609754
|
1190094-64-4
|
|
Tetradecyl sulfate sodium
|
十四烷基磺酸鈉
|
1191-50-0
|
|
PKI-179
|
PKI-179
|
1197160-28-3
|
|
PIM447
|
LGH447
|
1210608-43-7
|
|
Relenopride hydrochloride
|
Relenopride
|
1221416-42-7
|
|
DS-7423
|
DS 7423)
|
1222104-37-1
|
|
Redaporfin
|
Redaporfin
|
1224104-08-8
|
|
BMS-986094
|
N-(2'-C-甲基-6-O-甲基-P-1-萘基-5'-鳥苷?；?-L-丙氨酸 2,2-二甲基丙酯
|
1234490-83-5
|
|
Ifidancitinib
|
IFIDANCITINIB
|
1236667-40-5
|
|
Osilodrostat phosphate
|
LCI 699;LCI-699
|
1315449-72-9
|
|
Enzaplatovir
|
Enzaplatovir
|
1323077-89-9
|
|
Sovesudil
|
化合物 SOVESUDIL
|
1333400-14-8
|
|
Corydine
|
5-FLUORO-1-(2',3'-DIDEOXY-2',3'-DIDEHYDRO-B-D-ARABINOFURANOSYL)-CYTOSINE
|
134379-77-4
|
|
Orismilast
|
IBI353
|
1353546-86-7
|
|
Osavampator
|
9-(4-(環(huán)己氧基)苯基)-7-甲基-3,4-二氫吡嗪[2,1-C][1,2,4]噻二嗪-2,2-二氧化物
|
1358751-06-0
|
|
Alteminostat
|
Alteminostat
|
1246374-97-9
|
|
MKC-1
|
化合物MKC-1
|
125313-92-0
|
|
Dapaconazole
|
1-[2-(2,4-二氯苯基)-2-[[4-(三氟甲基)苯基]甲氧基]乙基]-1H-咪唑
|
1269726-67-1
|
|
Demeclocycline
|
地美環(huán)素
|
127-33-3
|
|
EGFR-IN-70
|
Selatinib
|
1275595-86-2
|
|
Cavosonstat
|
CAVOSONSTAT (N91115)
|
1371587-51-7
|
|
Afizagabar
|
5-(4-Fluoro-1-benzothiophen-2-yl)-8-methyl-1,9-dihydro-2H-[1,3]oxazolo[4,5-H][2,3]benzodiazepin-2-one
|
1398496-82-6
|
|
Zandelisib
|
ME-401
|
1401436-95-0
|
|
QS-21
|
皂苷 QA 21V1
|
141256-04-4
|
|
Sovleplenib
|
(S)-7-(4-(1-(methylsulfonyl)piperidin-4-yl)phenyl)-N-(morpholin-2-ylmethyl)pyrido[3,4-b]pyrazin-5-amine
|
1415792-84-5
|
|
Iclepertin
|
BI-425809
|
1421936-85-7
|
|
Tucatinib hemiethanolate
|
妥卡替尼半乙醇合物
|
1429755-56-5
|
|
BMS-963272
|
BMS-963272
|
1441057-15-3
|
|
GSK2647544
|
化合物 GSK2647544
|
1380426-95-8
|
|
BAZ1A-IN-1
|
化合物BAZ1A-IN-1
|
941521-45-5
|
|
Acetazolamide sodium
|
乙酰唑胺鈉
|
1424-27-7
|
|
Danvatirsen
|
AZD9150
|
1402357-06-5
|
|
Tigulixostat
|
化合物 TIGULIXOSTAT
|
1287766-55-5
|
|
Ifebemtinib
|
1227948-82-4
|
1227948-82-4
|